NU
NUS.F Nu Skin Enterprises Inc
- Market cap
- EUR 169M
- P/E
- -
- P/B
- 0.36x
- ROE
- -60.6%
- Dividend yield
- 6.00%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NUS.F undervalued?
Graham numberThe Graham number of Nu Skin Enterprises Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nu Skin Enterprises Inc fundamental analysis
No fundamental analysis for Nu Skin Enterprises Inc yet.
Nu Skin Enterprises Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provide…
Full company profileNu Skin Enterprises Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nu Skin Enterprises Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.21B | 2.28B | 2.68B | 2.42B | 2.58B | 2.70B | 2.23B | 1.97B | 1.73B | 1.49B | 1.27B |
| Gross Profit | 1.71B | 1.78B | 2.04B | 1.84B | 1.92B | 2.02B | 1.59B | 1.36B | 1.18B | 1.03B | 847M |
| Operating Income | 231M | 274M | 312M | 267M | 258M | 286M | 159M | 68.1M | 50.8M | 90.9M | 40.7M |
| EBITDA | - | 346M | 395M | 344M | 332M | 362M | 175M | 123M | -78.8M | 262M | -13.4M |
| Net Income | 143M | 129M | 122M | 174M | 191M | 147M | 105M | 8.60M | -147M | 160M | -332M |
| EPS | - | 2.46 | 2.20 | 3.12 | 3.76 | 2.95 | 2.12 | 0.17 | -2.94 | 3.32 | -6.81 |
| Balance Sheet | |||||||||||
| Total Assets | 1.47B | 1.59B | 1.69B | 1.77B | 1.96B | 1.91B | 1.82B | 1.81B | 1.47B | 1.41B | 1.09B |
| Total Liabilities | 810M | 885M | 913M | 894M | 1.06B | 994M | 924M | 984M | 817M | 600M | 541M |
| Shareholders' Equity | 664M | 705M | 782M | 875M | 894M | 913M | 897M | 822M | 651M | 805M | 547M |
| Cash & Short-term Investments | 357M | 426M | 387M | 336M | 403M | 340M | 265M | 256M | 187M | 239M | 165M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 275M | 303M | 203M | 178M | 379M | 142M | 108M | 90.0M | 112M | 80.3M | -1.89M |
| Capital Expenditure | 50.2M | 60.2M | 70.4M | 66.1M | 63.8M | 68.6M | 59.1M | 51.9M | 41.6M | 34.3M | 40.9M |
| Free Cash Flow | - | 242M | 132M | 112M | 315M | 73.0M | 49.0M | 38.1M | 70.2M | 46.0M | -42.8M |
| Ratios | |||||||||||
| ROE | 21.5% | 18.4% | 15.6% | 19.8% | 21.4% | 16.1% | 11.7% | 1.0% | -22.5% | 19.9% | -60.6% |
| ROA | 9.7% | 8.1% | 7.2% | 9.8% | 9.8% | 7.7% | 5.8% | 0.5% | -10.0% | 11.4% | -30.5% |
| Net Profit Margin | 6.5% | 5.7% | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% | -26.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Nu Skin Enterprises Inc dividends
- Dividend yield
- 6.00%
- Forward dividend
- 0.21 EUR
- Payout ratio
- 7.4%
- Ex-dividend date
- Nov 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 11.8M | 0.25 | 7.4% |
| 2024 | USD 11.9M | 0.24 | - |
| 2023 | USD 77.4M | 1.56 | 900.3% |
| 2022 | USD 77.0M | 1.56 | 73.5% |
| 2021 | USD 76.3M | 1.53 | 51.8% |
| 2020 | USD 78.4M | 1.54 | 41.0% |
| 2019 | USD 82.2M | 1.48 | 47.4% |
| 2018 | USD 80.6M | 1.45 | 66.1% |
| 2017 | USD 76.1M | 1.45 | 58.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Nu Skin Enterprises Inc
- Insiders 3.40%
- Institutions 75.31%
- Public & others 21.30%
- Shares outstanding 48.7M
- Free float 47.3M
Nu Skin Enterprises Inc company profile
- Company name
- Nu Skin Enterprises Inc
- Ticker
- NUS.F
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 2,800
- Fiscal year end
- December
- Address
- 75 West Center Street, Provo, UT, United States, 84601
- Phone
- 801 345 1000
- Website
- nuskin.com
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Nu Skin Enterprises Inc management
10- Mr. Steven J. Lund J.D.Co-Founder & Executive Chairman of the Board · born 1953
- Mr. Ryan S. NapierskiPresident, CEO & Director · born 1974
- Mr. Chayce David ClarkExecutive VP, COO & Chief Legal Officer · born 1983
- Mr. Justin S. KeiselExecutive VP & President of Global Sales (Leave of Absence) · born 1974
- Mr. Blake M. RoneyFounder · born 1959
- Ms. Sandra N. TillotsonFounder · born 1957
- Ms. Chelsea LantzChief Financial Officer · born 1984
- Mr. Joe SueperSenior VP & CTO
- Dr. Joseph Y. Chang Ph.D.Executive VP, Chief Scientific Officer & Chair of Scientific Advisory Board · born 1953
- Mr. B.G. HuntVP of Treasurer, Investor Relations & Admin Services